Joori Park

Stock Analyst at Leerink Partners

(n/a)
# 4,558
Out of 4,760 analysts
1
Total ratings
n/a
Success rate
-60.67%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Joori Park

Larimar Therapeutics
Apr 3, 2024
Initiates: Outperform
Price Target: $25
Current: $2.88
Upside: +768.06%